Abstract
Cold allodynia, pain in response to cooling, occurs during or within hours of oxaliplatin infusion and is thought to arise from a direct effect of oxaliplatin on peripheral sensory neurons. To characterize the pathophysiological mechanisms underlying acute oxaliplatin-induced cold allodynia, we established a new intraplantar oxaliplatin mouse model that rapidly developed long-lasting cold allodynia mediated entirely through tetrodotoxin-sensitive Nav pathways. Using selective inhibitors and knockout animals, we found that Nav1.6 was the key isoform involved, while thermosensitive transient receptor potential channels were not involved. Consistent with a crucial role for delayed-rectifier potassium channels in excitability in response to cold, intraplantar administration of the K(+)-channel blocker 4-aminopyridine mimicked oxaliplatin-induced cold allodynia and was also inhibited by Nav1.6 blockers. Intraplantar injection of the Nav1.6 activator Cn2 elicited spontaneous pain, mechanical allodynia, and enhanced 4-aminopyridine-induced cold allodynia. These findings provide behavioural evidence for a crucial role of Nav1.6 in multiple peripheral pain pathways including cold allodynia.
Keywords:
Allodynia; Voltage-gated sodium channel.
Copyright © 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
4-Aminopyridine / adverse effects
-
Analysis of Variance
-
Animals
-
Antineoplastic Agents / toxicity*
-
Cold Temperature / adverse effects
-
Disease Models, Animal
-
Dose-Response Relationship, Drug
-
Gene Expression Regulation / drug effects
-
Gene Expression Regulation / genetics
-
Hyperalgesia / chemically induced*
-
Male
-
Membrane Potentials / drug effects
-
Membrane Potentials / genetics
-
Mice
-
Mice, Inbred C57BL
-
Mice, Transgenic
-
NAV1.3 Voltage-Gated Sodium Channel / genetics
-
NAV1.3 Voltage-Gated Sodium Channel / metabolism
-
NAV1.6 Voltage-Gated Sodium Channel / genetics
-
NAV1.6 Voltage-Gated Sodium Channel / metabolism*
-
NAV1.9 Voltage-Gated Sodium Channel / genetics
-
NAV1.9 Voltage-Gated Sodium Channel / metabolism
-
Neuralgia / complications*
-
Neuralgia / genetics
-
Organoplatinum Compounds / toxicity*
-
Oxaliplatin
-
Potassium Channel Blockers / pharmacology
-
TRPA1 Cation Channel
-
TRPM Cation Channels / deficiency
-
Transient Receptor Potential Channels / deficiency
Substances
-
Antineoplastic Agents
-
NAV1.3 Voltage-Gated Sodium Channel
-
NAV1.6 Voltage-Gated Sodium Channel
-
NAV1.9 Voltage-Gated Sodium Channel
-
Organoplatinum Compounds
-
Potassium Channel Blockers
-
Scn11a protein, mouse
-
Scn3a protein, mouse
-
Scn8a protein, mouse
-
TRPA1 Cation Channel
-
TRPM Cation Channels
-
TRPM8 protein, mouse
-
Transient Receptor Potential Channels
-
Trpa1 protein, mouse
-
Oxaliplatin
-
4-Aminopyridine